SVS, ACC complete move to single vascular registry

The Society for Vascular Surgery (SVS) and the American College of Cardiology (ACC) have completed a move to create a single vascular registry. The new joint venture is designed to harness the strengths of both organizations in improving care and…
How to succeed in vascular surgery: A guide for the aspiring outlier

Disclaimer: The views expressed here do not reflect those of Mayo Clinic, the Society for Vascular Surgery, Vascular Specialist, or even the author, for that matter. It’s satirical—everybody relax. Our recent paper, “Practice patterns of vascular surgery’s ‘1%’” created a…
LINC 2021: Long-term data show sustained efficacy and safety of paclitaxel devices in fempop lesions

A key theme among the late-breaking trial data presented at the recent LINC 2021 (the Leipzig Interventional Course), held digitally from Jan. 25–29, was the emergence of long-term evidence on paclitaxel devices in the femoropopliteal segment. Results out to five years shows…
COVID-19 pandemic led to ‘severe’ financial loss for academic vascular surgery division

The initial stages of the COVID-19 pandemic resulted in three-month sustained decreases in operative and outpatient clinical volume as well as a “severe” financial loss for a U.S. academic vascular surgery division, researchers from a prominent health system in an…
Democrats take control with Biden presidency, majorities in both chambers

Democratic victories for Georgia’s two Senate seats in the runoff election Jan. 5 have solidified the Democrats’ control of the federal government for the next two years. The victories by Democrats Rev. Raphael Warnock over incumbent Sen. Kelly Loeffler and…
SVS Foundation’s new initiative to address disparities in vascular health

Significant disparities in healthcare services in the United States result in unnecessary limb loss, stroke and death. Vascular health professionals are developing new programs to address these inequities, through the Society for Vascular Surgery (SVS) Foundation. The SVS Foundation Volunteers…
Lymphedema: NYC vascular surgeon explains experience tackling severe cases with a modified Charles’ procedure

Kuldeep Singh, MD, calls them a labor of love. They are tough—the patients having endured repeated hospitalizations, infections, embarrassment: The sorts of severely affected lymphedema cases he ends up treating find individuals in the end stage of the disease and…
Patients with depression ‘less likely’ to go home after CLTI revascularization

A recent analysis established an association between depression and non-home discharge after revascularization for chronic limb-threatening ischemia (CLTI)—providing further evidence, the authors say, that an increased awareness of mental health is fundamental to care for vascular surgery patients. Joel L.…
SVS online education hub goes live

The Society for Vascular Surgery (SVS) has launched its Education Portal, linking to eagerly anticipated new learning management system (LMS) SVS OnDemand. Education Committee chair Kellie Brown, MD, hailed the site an online hub that covers all educational needs. Links…
Five-year ILLUMENATE results confirm safety profile of Philips Stellarex DCB

Royal Philips has announced the final, five-year results of two randomized controlled trials (RCTs) that show no difference in all-cause mortality between patients treated with the Stellarex drug-coated balloon (DCB) and those treated with percutaneous transluminal angioplasty (PTA), the current standard…

